Michael Allen Company has been Acquired by M3

February 2023

About Michael Allen Company

Michael Allen Company is a leading biopharma consultancy with end-to-end platforms primed for growth and backed by over 20 years of specialized experience. The Company provides focused expertise and versatile scalable research platforms to develop cutting-edge solutions to clients’ business problems. Michael Allen has solid relationships with pharmaceutical companies and methodologies to support clients’ product development according to its process from Phase 1-3 to pre-launch, launch, and inline.

About M3

M3 operates m3.com, a specialized web portal for medical professionals that delivers healthcare-related information to its 310,000+ physician members in Japan. Presence outside of Japan includes the U.S., U.K., France, China, Korea, and India, with aggressive business expansion overseas that has amassed 6 million physicians across its global platforms. This allows the delivery of services, including marketing support, marketing research, and job placement support, that leverage the platform’s value as a media channel.

Sale to

Transaction Details

Get in touch with us

Contact Us

  • Hidden
  • This field is for validation purposes and should be left unchanged.